Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

8XV4

Crystal structure of TTD-PHD domain of UHRF1 in complex with mStella peptide (residues 85-119)

Summary for 8XV4
Entry DOI10.2210/pdb8xv4/pdb
DescriptorE3 ubiquitin-protein ligase UHRF1, Developmental pluripotency-associated protein 3, ZINC ION, ... (4 entities in total)
Functional Keywordsuhfr1, stella, complex, inhibitor, gene regulation, gene regulation-inhibitor complex, gene regulation/inhibitor
Biological sourceHomo sapiens (human)
More
Total number of polymer chains4
Total formula weight61970.02
Authors
Du, X.,Gan, Q.,Xu, J.,Liu, J. (deposition date: 2024-01-14, release date: 2024-11-06, Last modification date: 2025-02-19)
Primary citationBai, W.,Xu, J.,Gu, W.,Wang, D.,Cui, Y.,Rong, W.,Du, X.,Li, X.,Xia, C.,Gan, Q.,He, G.,Guo, H.,Deng, J.,Wu, Y.,Yen, R.C.,Yegnasubramanian, S.,Rothbart, S.B.,Luo, C.,Wu, L.,Liu, J.,Baylin, S.B.,Kong, X.
Defining ortholog-specific UHRF1 inhibition by STELLA for cancer therapy.
Nat Commun, 16:474-474, 2025
Cited by
PubMed Abstract: UHRF1 maintains DNA methylation by recruiting DNA methyltransferases to chromatin. In mouse, these dynamics are potently antagonized by a natural UHRF1 inhibitory protein STELLA, while the comparable effects of its human ortholog are insufficiently characterized, especially in cancer cells. Herein, we demonstrate that human STELLA (hSTELLA) is inadequate, while mouse STELLA (mSTELLA) is fully proficient in inhibiting the abnormal DNA methylation and oncogenic functions of UHRF1 in human cancer cells. Structural studies reveal a region of low sequence homology between these STELLA orthologs that allows mSTELLA but not hSTELLA to bind tightly and cooperatively to the essential histone-binding, linked tandem Tudor domain and plant homeodomain (TTD-PHD) of UHRF1, thus mediating ortholog-specific UHRF1 inhibition. For translating these findings to cancer therapy, we use a lipid nanoparticle (LNP)-mediated mRNA delivery approach in which the short mSTELLA, but not hSTELLA regions are required to reverse cancer-specific DNA hypermethylation and impair colorectal cancer tumorigenicity.
PubMed: 39774694
DOI: 10.1038/s41467-024-55481-7
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (3.2 Å)
Structure validation

234785

PDB entries from 2025-04-16

PDB statisticsPDBj update infoContact PDBjnumon